What Is the Treatment Durability and Safety Profile of Rheumatoid Arthritis Patients Treated with Infliximab Plus Methotrexate and/or Leflunomide? An Analysis from the Real-world Registry, BioTRAC

Faraawi Rafat; Joshi Ramen; Bensen William; Choquette Denis; Olszynski Wojciech; Arendse Regan; Sheriff Maqbool; Rahman Proton; Sampalis John; Rampakakis Emmanouil; Nantel Francois; Lehman Allen; Otawa Susan

首页> 外文期刊>The Journal of rheumatology >What Is the Treatment Durability and Safety Profile of Rheumatoid Arthritis Patients Treated with Infliximab Plus Methotrexate and/or Leflunomide? An Analysis from the Real-world Registry, BioTRAC

【24h】

What Is the Treatment Durability and Safety Profile of Rheumatoid Arthritis Patients Treated with Infliximab Plus Methotrexate and/or Leflunomide? An Analysis from the Real-world Registry, BioTRAC

机译：用英夫利昔单抗加甲氨蝶呤和/或来氟米特治疗的类风湿关节炎患者的治疗耐久性和安全性如何？现实世界注册表BioTRAC的分析

获取原文

获取原文并翻译 | 示例

掌桥外文数据库（机构版） >>

开具论文收录证明 >>

文献代查 >>

页面导航

著录项
相似文献
相关主题

著录项

来源
《The Journal of rheumatology》 |2015年第7期|共1页
作者
Faraawi Rafat; Joshi Ramen; Bensen William; Choquette Denis; Olszynski Wojciech; Arendse Regan; Sheriff Maqbool; Rahman Proton; Sampalis John; Rampakakis Emmanouil; Nantel Francois; Lehman Allen; Otawa Susan;
展开▼
作者单位

展开▼
收录信息
原文格式 PDF
正文语种 eng
中图分类免疫性疾病;
关键词

相似文献

外文文献
中文文献
专利

1. What Is the Treatment Durability and Safety Profile of Rheumatoid Arthritis Patients Treated with Infliximab Plus Methotrexate and/or Leflunomide? An Analysis from the Real-world Registry, BioTRAC [J] . Faraawi Rafat, Joshi Ramen, Bensen William, The Journal of rheumatology . 2015,第7期

机译：用英夫利昔单抗加甲氨蝶呤和/或来氟米特治疗的类风湿关节炎患者的治疗耐久性和安全性如何？现实世界注册表BioTRAC的分析
2. Effectiveness and Safety of Infliximab in the Management of Psoriatic Arthritis: Real-World Data from the Biologic Treatment Registry Across Canada (BioTRAC) [J] . Rahman Proton, Choquette Denis, Chow Andrew, The Journal of rheumatology . 2019,第7期

机译：英夫利昔单抗在银屑病关节炎管理中的有效性和安全性：来自加拿大的生物治疗登记处的现实世界数据（Biotrac）
3. Comparison of Baseline Characteristics of Rheumatoid Arthritis Patients Initiating Therapy with Subcutaneous Golimumab and Infliximab and Intravenous Golimumab: An Analysis from the Prospective, Observational Registry, BioTRAC [J] . Faraawi Rafat, Olszynski Wojciech, Chow Andrew, The Journal of rheumatology . 2016,第6期

机译：皮下注射戈利木单抗，英夫利昔单抗和戈利木单抗静脉治疗的类风湿关节炎患者基线特征的比较：前瞻性，观察性登记，BioTRAC分析
4. Inflammatory gene profile in early rheumatoid arthritis and odulation by leflunomide and prednisone treatment [C] . Mgurizio Cutolo, Barbara Villaggio, Carmen Pizzorni, International Conference on the Neuroendocrine Immune Basis of the Rheumatic Diseases . 2010

机译：早期类风湿性关节炎和偏血清血清血清炎和泼尼松治疗的炎症基因谱
5. The Efficacy of Therapeutic Drug Monitoring of Rheumatoid Arthritis Patients on Infliximab [D] . Abolhosn, Rania. 2018

机译：类风湿性关节炎患者治疗药物监测对英夫利昔单抗的疗效
6. Clinical Analysis of Chinese Patients With Rheumatoid Arthritis Treated With Leflunomide and Methotrexate Combined With Different Dosages of Glucocorticoid [O] . Cong-zhu Ding, Yao Yao, Xue-bing Feng, 2012

机译：来氟米特和甲氨蝶呤联合不同剂量糖皮质激素治疗中国类风湿关节炎的临床分析
7. PAM12: COST-MINIMIZATION ANALYSIS OF THE TREATMENT OF RHEUMATOID ARTHRITIS WITH LEFLUNOMIDE IN COMPARISON WITH THE COMBINATION OF INFLIXIMAB AND METHOTREXATE [O] . Rubio-Terrés C, Domínguez-Gil A 2001

机译：PAM12：与来氟米特联合甲氨蝶呤和甲氨蝶呤治疗类风湿关节炎的左芬诺胺的成本最小化分析

What Is the Treatment Durability and Safety Profile of Rheumatoid Arthritis Patients Treated with Infliximab Plus Methotrexate and/or Leflunomide? An Analysis from the Real-world Registry, BioTRAC

著录项

相似文献

相关主题

期刊订阅